Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Stephen Johnston | Researchclopedia

Back to researchers

Stephen Johnston

Royal Marsden NHS Foundation Trust ORCID

480

Works

17,011

Citations

62

h-index

168

i10-index

Research Topics

Advanced Breast Cancer Therapies HER2/EGFR in Cancer Research Estrogen and related hormone effects

Affiliations

University of Southern California2013–2013

Universidad Complutense de Madrid2018–2018

National Health Service2010–2022

Belfast Health and Social Care Trust2019–2019

BC Cancer Agency2019–2019

Top Works

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer

Stephen Johnston,John Pippen,et al.

20091,023 citations

Cancer Treatment and Pharmacology

Breast Cancer Treatment Studies

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2

George W. Sledge,Masakazu Toi,et al.

2019964 citations

Plasma <i>ESR1</i> Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer

Charlotte Fribbens,Ben O’Leary,et al.

2016703 citations

MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

Stephen Johnston,Miguel Martín,et al.

2019661 citations

Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

Hope S. Rugo,R. Bryan Rumble,et al.

2016635 citations

Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial

Stephen Johnston,Masakazu Toi,et al.

2022527 citations

Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase

Maya Gutierrez,Simone Detre,et al.

2005488 citations

Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer

Isaac García-Murillas,Neha Chopra,et al.

2019418 citations

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial

Angelo Di Leo,Stephen Johnston,et al.

2017379 citations